Skip to main content
Hamid Mirshahidi, MD, Oncology, Loma Linda, CA

HamidRezaMirshahidiMD

Oncology Loma Linda, CA

Breast Cancer, Thoracic Cancer

Professor, Medicine, Loma Linda University School of Medicine

Dr. Mirshahidi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mirshahidi's full profile

Already have an account?

  • Office

    11234 Anderson St
    Loma Linda, CA 92354
    Phone+1 909-558-2262
    Fax+1 909-651-5939

Summary

  • Dr. Hamid Mirshahidi is an oncologist in Loma Linda, CA and is affiliated with Loma Linda University Medical Center. He received his medical degree from Marmara University Faculty of Medicine and has been in practice 25 years. He specializes in hematologic oncology.

Education & Training

  • West Virginia University
    West Virginia UniversityFellowship, Hematology and Medical Oncology, 2002 - 2005
  • Trinity Health Oakland/Wayne State University
    Trinity Health Oakland/Wayne State UniversityResidency, Internal Medicine, 1999 - 2002
  • Marmara Univ- Fac Med
    Marmara Univ- Fac MedClass of 1992

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2026
  • MI State Medical License
    MI State Medical License 1999 - 2018
  • WV State Medical License
    WV State Medical License 2002 - 2017
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Best Doctors in Inland Empire 2008
  • Margaret J. Albrink Research Award West Virginia University, 2005

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Nivolumab-induced pericardial effusion  
    Sheehen S, Mirshahidi HR, Nagaraj G, Hsueh CT, Lung Cancer. Exp Hematol Oncol, 1/1/2018
  • Metastatic Biomarkers In Synovial Sarcoma  
    Necochea-Campion RD, Zuckerman LM; Mirshahidi HR, Khosrowpour S, Chen CS, Mirshahidi S, Biomarker Research, 1/7/2017
  • SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete res...  
    Nahleh ZA, Barlow WE, Hayes DF, Schott AF, Gralow JR, Sikov WM, Perez EA, Chennuru S, Mirshahidi HR, Corso SW, Lew DL, Pusztai L, Livingston RB, Hortobagyi GN, Breast Cancer Res Treat., 1/1/2016
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Evidence-based conclusions and inclinations of pemetrexed, taxane and bevacizumab in advanced lung cancer.
    Shaheen S, Ji L, Morgan2JW, Otoukesh S, Mirshahidi HR., Journal of Thoracic Oncology. The 8th European Lung Cancer Congress (ELCC), Geneva, Switzerland, 1/11/2018
  • EGFR reporting in stage IV adenocarcinoma of the lung: Demographic predictors of EGFR testing and survival.
    Shaheen S, Ji L, Morgan2JW, Otoukesh S, Mirshahidi S, Mirshahidi HR, ASCO, Chicago, 1/1/2018
  • Antiproliferative effect of bupivacaine on patient-derived sarcoma cells.
    Zuckerman LM, Mirshahidi HR, Williams NL, Elsissy J, Shields TG, Otoukesh S, Mirshahidi S., The Connective Tissue Oncology Society., Rome, Italy, 1/1/2018
  • Join now to see all

Lectures

  • The effect of non-steroidal anti-inflammatory drugs on osteosarcoma cells 
    Loma Linda, CA - 1/1/2019
  • Personalized Treatment for Lung Cancer 
    Loma Linda University - 1/1/2011
  • Suicide in Cancer Patients with Carcinoma of Lung and Bronchus in California, 1997-2006 
    Amsterdam, Netherland - 1/1/2011
  • Join now to see all

Other

  • Factors influencing the incidence of diarrhea in rural areas of the province Of Khorassan, Iran. 
    Mirshahidi HR
    University of Teheran, School of Medicine. Tehran, Iran - 1/1/1993
  • Sex education for young adults in Istanbul. 
    Mirshahidi HR.
    School of Medicine, Marmara University. Istanbul, Turkey, - 1/1/1991

Press Mentions

  • World Lung Cancer Day: Celebrating Advances in Care, Patient Resilience
    World Lung Cancer Day: Celebrating Advances in Care, Patient ResilienceAugust 1st, 2022